Listed

IGC Pharma, Inc.

IGCNYSECIK 1326205HealthcareFiscal year ends Dec 31

Reports and events: 271 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

IGC Pharma, Inc., Reports and events
FiledFormWhat it isAccession number
2018-09-1216:32 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001185185-18-001673
2018-08-0721:30 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001185185-18-001360
2018-08-0320:24 ET10-QQuarterly reportPeriod 2018-06-300001185185-18-001341
2018-07-0620:19 ETDEF 14AProxy statementPeriod 2018-08-060001185185-18-001222
2018-06-2117:18 ET10-KAnnual reportPeriod 2018-03-310001185185-18-001155
2018-05-1516:16 ET8-K5.02 Departure or appointment of officers or directors0001185185-18-000899
2018-05-0416:06 ET8-K8.01 Other events0001185185-18-000786
2018-04-1218:18 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001185185-18-000677
2018-03-1916:08 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001185185-18-000461
2018-03-0216:02 ET8-K8.01 Other events0001185185-18-000357
2018-02-2016:21 ET10-QQuarterly reportPeriod 2017-12-310001185185-18-000276
2018-01-0216:38 ET8-K5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001185185-18-000005
2017-12-2219:39 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001185185-17-002663
2017-12-1810:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-17-002626
2017-11-3021:14 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001185185-17-002517
2017-11-2217:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-17-002479
2017-11-1717:03 ET10-QQuarterly reportPeriod 2017-09-300001185185-17-002428
2017-11-1314:24 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001185185-17-002327
2017-10-1215:16 ET8-K3.01 Delisting notice; 9.01 Financial statements and exhibits0001185185-17-002152
2017-10-1017:39 ETDEF 14AProxy statementPeriod 2017-11-080001185185-17-002130
2017-09-2916:59 ET8-K5.02 Departure or appointment of officers or directors0001185185-17-002084
2017-08-1817:28 ET10-QQuarterly reportPeriod 2017-06-300001185185-17-001802
2017-07-1421:26 ET10-KAnnual reportPeriod 2017-03-310001185185-17-001544
2017-06-1209:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-17-001372
2017-05-2516:09 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-17-001264
2017-05-1219:56 ETSC 13DOwnership report, active investor0001185185-17-001114
2017-04-2508:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-17-000993
2017-04-2117:29 ET8-K3.01 Delisting notice; 9.01 Financial statements and exhibits0001185185-17-000987
2017-04-0521:54 ET8-K2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0001185185-17-000817
2017-04-0519:35 ET8-K3.01 Delisting notice; 9.01 Financial statements and exhibits0001185185-17-000815
2017-02-2815:45 ET8-K/A9.01 Financial statements and exhibits0001185185-17-000480
2017-02-2116:09 ET10-QQuarterly reportPeriod 2016-12-310001185185-17-000430
2017-02-1716:10 ET8-K3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001185185-17-000400
2017-01-0616:25 ET8-K2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0001185185-17-000025
2016-11-2109:20 ET10-QQuarterly reportPeriod 2016-09-300001185185-16-005839
2016-11-2108:33 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001185185-16-005835
2016-08-1616:22 ET10-QQuarterly reportPeriod 2016-06-300001185185-16-005260
2016-08-0417:10 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001185185-16-005098
2016-07-1416:07 ET10-KAnnual reportPeriod 2016-03-310001185185-16-004982
2016-05-2017:20 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001185185-16-004676
2016-04-0616:26 ET8-K2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001185185-16-004175
2016-03-3018:11 ET8-K3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001185185-16-004044
2016-03-1816:06 ET8-K3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001185185-16-003940
2016-03-0910:03 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-16-003868
2016-03-0108:00 ET8-K3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001185185-16-003804
2016-02-2917:00 ET8-K3.01 Delisting notice; 9.01 Financial statements and exhibits0001185185-16-003794
2016-02-1616:23 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001185185-16-003722
2016-02-1616:10 ET10-QQuarterly reportPeriod 2015-12-310001185185-16-003719
2015-11-1316:04 ET10-QQuarterly reportPeriod 2015-09-300001185185-15-002954
2015-08-2616:02 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001185185-15-002292

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 16:27 ET. Listed shows no prices and gives no investment advice.